Floatz logo

Cicaderma

Radiodermatitis

Centre Leon BerardUNKNOWNPhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Radiodermatitis cohort.

Asset / SponsorPhaseRating
Olea Europaea Oil
Cairo University
Phase 4BB
Urea
University of Brasilia
Phase 3BB
Flosteron
Cairo University
Phase 4BB
Chamomilla Recutita
University of Brasilia
Phase 3BB
Mometasone
North Central Cancer Treatment Group
Phase 3BB

View all 32 →

Same molecule, other indications

Cicaderma is also rated in:

breast adenocarcinomaDormant
B
Indicative · Phase 3
60 / 100
View asset →
radiation injuryDormant
B
Indicative · Phase 3
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →